COYA logo

Coya Therapeutics (COYA) EBITDA

Annual EBITDA

-$7.88 M
+$1.91 M+19.51%

December 31, 2023


Summary


Performance

COYA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCOYAprofitabilitymetrics:

Quarterly EBITDA

-$4.44 M
-$1.21 M-37.60%

September 30, 2024


Summary


Performance

COYA Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCOYAprofitabilitymetrics:

TTM EBITDA

-$11.33 M
-$886.20 K-8.49%

September 30, 2024


Summary


Performance

COYA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCOYAprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

COYA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+19.5%-24.9%+3.1%
3 y3 years--67.7%-20.8%
5 y5 years--67.7%-20.8%

COYA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-62.3%+19.5%-343.9%+18.9%-613.3%+3.1%
5 y5-year-62.3%+19.5%-343.9%+18.9%-613.3%+3.1%
alltimeall time-62.3%+19.5%-343.9%+18.9%-613.3%+3.1%

Coya Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$4.44 M(+37.6%)
-$11.33 M(+8.5%)
Jun 2024
-
-$3.23 M(-41.0%)
-$10.44 M(-0.2%)
Mar 2024
-
-$5.48 M(-400.6%)
-$10.46 M(+32.8%)
Dec 2023
-$7.88 M
$1.82 M(-151.2%)
-$7.88 M(-32.7%)
Sep 2023
-
-$3.56 M(+9.5%)
-$11.69 M(+8.4%)
Jun 2023
-
-$3.25 M(+12.2%)
-$10.79 M(-1.8%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$2.89 M(+44.9%)
-$10.98 M(+12.2%)
Dec 2022
-$9.78 M(+101.6%)
-$2.00 M(-24.6%)
-$9.78 M(+4.4%)
Sep 2022
-
-$2.65 M(-23.0%)
-$9.38 M(+39.4%)
Jun 2022
-
-$3.44 M(+102.9%)
-$6.73 M(+104.8%)
Mar 2022
-
-$1.70 M(+6.8%)
-$3.28 M(+106.8%)
Dec 2021
-$4.85 M
-
-
Dec 2021
-
-$1.59 M
-$1.59 M

FAQ

  • What is Coya Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Coya Therapeutics?
  • What is Coya Therapeutics annual EBITDA year-on-year change?
  • What is Coya Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Coya Therapeutics?
  • What is Coya Therapeutics quarterly EBITDA year-on-year change?
  • What is Coya Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Coya Therapeutics?
  • What is Coya Therapeutics TTM EBITDA year-on-year change?

What is Coya Therapeutics annual EBITDA?

The current annual EBITDA of COYA is -$7.88 M

What is the all time high annual EBITDA for Coya Therapeutics?

Coya Therapeutics all-time high annual EBITDA is -$4.85 M

What is Coya Therapeutics annual EBITDA year-on-year change?

Over the past year, COYA annual EBITDA has changed by +$1.91 M (+19.51%)

What is Coya Therapeutics quarterly EBITDA?

The current quarterly EBITDA of COYA is -$4.44 M

What is the all time high quarterly EBITDA for Coya Therapeutics?

Coya Therapeutics all-time high quarterly EBITDA is $1.82 M

What is Coya Therapeutics quarterly EBITDA year-on-year change?

Over the past year, COYA quarterly EBITDA has changed by -$886.20 K (-24.91%)

What is Coya Therapeutics TTM EBITDA?

The current TTM EBITDA of COYA is -$11.33 M

What is the all time high TTM EBITDA for Coya Therapeutics?

Coya Therapeutics all-time high TTM EBITDA is -$1.59 M

What is Coya Therapeutics TTM EBITDA year-on-year change?

Over the past year, COYA TTM EBITDA has changed by +$367.80 K (+3.15%)